What to know about Medicare drug price negotiation

In this episode, Todd Askew, AMA senior vice president of Advocacy, presents what physicians need to know about Medicare drug price negotiations for seniors in the US health care system. The topic has ebbed and flowed for many years and has recently been debated again in Congress. Allowing CMS to negotiate drug prices on behalf of its beneficiaries and private plan enrollees would help reduce out-of-pocket spending. Listen in to learn more.